$LLY
ELI LILLY & Co Stock $lly

$lly Overview Financials Valuation SEC Filings Company Website

2012 Q3 Form 10-Q Financial Statement

#000005947812000006 Filed on July 27, 2012

Income Statement

Concept	2012 Q3	2012 Q2	2011 Q2
Revenue	$5.443B	$5.601B	$6.253B
YoY Change	-11.46%	-10.43%	8.77%
Cost Of Revenue	$1.204B	$1.147B	$1.228B
YoY Change	-10.05%	-6.62%	19.93%
Gross Profit	$4.240B	$4.454B	$5.025B
YoY Change	-11.85%	-11.36%	6.35%
Gross Profit Margin	77.89%	79.53%	80.36%
Selling, General & Admin	$1.757B	$1.931B	$2.043B
YoY Change	-8.36%	-5.48%	16.38%
% of Gross Profit	41.45%	43.36%	40.66%
Research & Development	$1.343B	$1.321B	$1.261B
YoY Change	4.83%	4.77%	6.18%
% of Gross Profit	31.67%	29.65%	25.09%
Depreciation & Amortization	$369.7M	$362.0M	$355.6M
YoY Change	3.21%	1.8%	2.89%
% of Gross Profit	8.72%	8.13%	7.08%
Operating Expenses	$3.100B	$3.252B	$3.304B
YoY Change	-3.08%	-1.57%	12.27%
Operating Profit	$1.140B	$1.202B	$1.721B
YoY Change	-29.27%	-30.15%	-3.42%
Interest Expense	$47.00M	$43.00M	$45.10M
YoY Change	4.44%	-4.66%	-223.56%
% of Operating Profit	4.12%	3.58%	2.62%
Other Income/Expense, Net	$788.5M	-$16.50M	-$57.60M
YoY Change	-1045.44%	-71.35%	-418.23%
Pretax Income	$1.875B	$1.186B	$1.531B
YoY Change	24.77%	-22.57%	-11.82%
Income Tax	$548.1M	$262.1M	$334.0M
% Of Pretax Income	29.24%	22.11%	21.81%
Net Earnings	$1.327B	$923.6M	$1.197B
YoY Change	7.3%	-22.86%	-11.24%
Net Earnings / Revenue	24.37%	16.49%	19.15%
Basic Earnings Per Share	$1.18	$0.83
Diluted Earnings Per Share	$1.18	$0.83	$1.075M
COMMON SHARES
Basic Shares Outstanding	1.160B shares
Diluted Shares Outstanding

Balance Sheet

Concept	2012 Q3	2012 Q2	2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.900B	$5.262B	$6.330B
YoY Change	1.71%	-16.87%	21.8%
Cash & Equivalents	$5.319B	$4.346B	$6.114B
Short-Term Investments	$1.581B	$916.0M	$216.0M
Other Short-Term Assets	$790.0M	$953.0M	$1.304B
YoY Change	-32.94%	-26.92%	-9.57%
Inventory	$2.553B	$2.321B	$2.870B
Prepaid Expenses	$790.1M	$953.3M
Receivables	$3.268B	$3.182B	$3.834B
Other Receivables	$528.0M	$590.0M	$613.0M
Total Short-Term Assets	$14.04B	$12.31B	$14.95B
YoY Change	-3.66%	-17.68%	19.93%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.639B	$7.620B	$7.954B
YoY Change	-2.22%	-4.2%	2.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$5.224B	$4.548B	$2.943B
YoY Change	62.24%	54.54%	176.34%
Other Assets	$2.388B	$2.195B	$1.977B
YoY Change	7.75%	11.03%	-16.65%
Total Long-Term Assets	$12.64B	$11.89B	$17.83B
YoY Change	-31.54%	-33.34%	16.86%
TOTAL ASSETS
Total Short-Term Assets	$14.04B	$12.31B	$14.95B
Total Long-Term Assets	$12.64B	$11.89B	$17.83B
Total Assets	$34.32B	$31.81B	$32.78B
YoY Change	3.87%	-2.95%	18.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.329B	$1.202B	$1.188B
YoY Change	15.14%	1.14%	25.05%
Accrued Expenses	$773.0M	$603.0M	$585.0M
YoY Change	12.19%	3.08%	-0.17%
Deferred Revenue
YoY Change
Short-Term Debt	$9.100M	$9.100M	$1.529B
YoY Change	-99.44%	-99.4%	5562.96%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.961B	$6.610B	$8.621B
YoY Change	-15.31%	-23.33%	36.3%
LONG-TERM LIABILITIES
Long-Term Debt	$5.511B	$5.500B	$5.200B
YoY Change	1.1%	5.77%	-24.22%
Other Long-Term Liabilities	$1.815B	$1.473B	$4.682B
YoY Change	-57.93%	-68.54%	10.95%
Total Long-Term Liabilities	$11.30B	$10.90B	$9.882B
YoY Change	15.75%	10.25%	-10.83%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.961B	$6.610B	$8.621B
Total Long-Term Liabilities	$11.30B	$10.90B	$9.882B
Total Liabilities	$18.26B	$17.50B	$18.50B
YoY Change	1.57%	-5.4%	5.84%
SHAREHOLDERS EQUITY
Retained Earnings	$17.06B	$15.74B
YoY Change
Common Stock	$5.646B	$5.616B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$94.30M	$94.30M
YoY Change
Treasury Stock Shares
Shareholders Equity	$16.07B	$14.31B	$14.28B
YoY Change
Total Liabilities & Shareholders Equity	$34.32B	$31.81B	$32.78B
YoY Change	3.87%	-2.95%	18.24%

Cashflow Statement

Concept	2012 Q3	2012 Q2	2011 Q2
OPERATING ACTIVITIES
Net Income	$1.327B	$923.6M	$1.197B
YoY Change	7.3%	-22.86%	-11.24%
Depreciation, Depletion And Amortization	$369.7M	$362.0M	$355.6M
YoY Change	3.21%	1.8%	2.89%
Cash From Operating Activities	$1.544B	$1.306B	$2.040B
YoY Change	-25.52%	-35.99%	6.73%
INVESTING ACTIVITIES
Capital Expenditures	-$284.0M	-$179.5M	-$542.2M
YoY Change	-18.53%	-66.89%	-2.17%
Acquisitions
YoY Change
Other Investing Activities	$151.3M	-$205.8M	-$1.356B
YoY Change	-122.93%	-84.83%	578.2%
Cash From Investing Activities	-$132.7M	-$385.3M	-$1.899B
YoY Change	-86.84%	-79.71%	151.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-544.7M	-552.7M	-564.3M
YoY Change	23.54%	-2.06%	6.17%
NET CHANGE
Cash From Operating Activities	1.544B	1.306B	2.040B
Cash From Investing Activities	-132.7M	-385.3M	-1.899B
Cash From Financing Activities	-544.7M	-552.7M	-564.3M
Net Change In Cash	866.9M	368.0M	-422.6M
YoY Change	38.88%	-187.08%	-167.52%
FREE CASH FLOW
Cash From Operating Activities	$1.544B	$1.306B	$2.040B
Capital Expenditures	-$284.0M	-$179.5M	-$542.2M
Free Cash Flow	$1.828B	$1.486B	$2.583B
YoY Change	-24.51%	-42.48%	4.73%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
CY2012Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	590000000	USD
CY2011Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	640200000	USD
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1125200000	USD
CY2012Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1201600000	USD
CY2011Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3597700000	USD
CY2012Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3181700000	USD
CY2011Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	261600000	USD
CY2012Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	33500000	USD
CY2011Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	1086300000	USD
CY2012Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	1207500000	USD
CY2011Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6833700000	USD
CY2012Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7085700000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3858600000	USD
CY2012Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3934200000	USD
CY2011Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	4886800000	USD
CY2012Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	4890100000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	65800000	USD
CY2011Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	36300000	USD
CY2012Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	34800000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	74200000	USD
CY2011Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	110100000	USD
CY2012Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	108300000	USD
CY2011Q4	us-gaap	Assets Assets	33659800000	USD
CY2012Q2	us-gaap	Assets Assets	31812600000	USD
CY2012Q2	us-gaap	Assets Current AssetsCurrent	12307300000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	14248200000	USD
CY2012Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	11885400000	USD
CY2011Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	11651300000	USD
CY2012Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	1469400000	USD
CY2011Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	2164400000	USD
CY2012Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	4280000000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	88000000	USD
CY2011Q2	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	48600000	USD
CY2012Q2	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	13200000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	26900000	USD
CY2011Q2	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	1600000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	5100000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	5200000	USD
CY2012Q2	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	2500000	USD
CY2012Q2	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	51800000	USD
CY2011Q4	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	80000000	USD
CY2012Q2	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	136000000	USD
CY2011Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	103000000	USD
CY2012Q2	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Other Percentage Of Nonperforming Assets AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureOtherPercentageOfNonperformingAssets	0.90
CY2012Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability	50000000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4345800000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5922500000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5993200000	USD
CY2011Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6113500000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1576700000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	120300000	USD
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.98
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.98
CY2012Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.49
CY2011Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.49
CY2011Q4	us-gaap	Common Stock Shares Held In Employee Trust CommonStockSharesHeldInEmployeeTrust	3013100000	USD
CY2012Q2	us-gaap	Common Stock Shares Held In Employee Trust CommonStockSharesHeldInEmployeeTrust	3013200000	USD
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	724100000	USD
CY2012Q2	us-gaap	Common Stock Value CommonStockValue	725800000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2913400000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1859100000	USD
CY2011Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1376200000	USD
CY2012Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	538600000	USD
CY2011Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1228000000	USD
CY2012Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1146700000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2344600000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2408100000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	696500000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	747900000	USD
	us-gaap	Derivative Instruments Gain Loss Recognized In Income Net DerivativeInstrumentsGainLossRecognizedInIncomeNet	-14800000	USD
CY2011Q2	us-gaap	Derivative Instruments Gain Loss Recognized In Income Net DerivativeInstrumentsGainLossRecognizedInIncomeNet	20700000	USD
CY2012Q2	us-gaap	Derivative Instruments Gain Loss Recognized In Income Net DerivativeInstrumentsGainLossRecognizedInIncomeNet	18000000	USD
	us-gaap	Derivative Instruments Gain Loss Recognized In Income Net DerivativeInstrumentsGainLossRecognizedInIncomeNet	50700000	USD
	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	0	USD
CY2011Q2	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	35800000	USD
	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	25800000	USD
	us-gaap	Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion	4500000	USD
CY2012Q2	us-gaap	Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion	2200000	USD
	us-gaap	Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion	4400000	USD
CY2011Q2	us-gaap	Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion	2300000	USD
CY2011Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	542300000	USD
CY2012Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	543600000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	1.73
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	2.02
CY2012Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.83
CY2011Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	1.07
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	121300000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-87900000	USD
CY2011Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	804700000	USD
CY2012Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	602900000	USD
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	7100000	USD
CY2011Q2	us-gaap	Impairment Of Investments ImpairmentOfInvestments	6600000	USD
CY2012Q2	us-gaap	Impairment Of Investments ImpairmentOfInvestments	3700000	USD
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	7400000	USD
CY2012Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1185700000	USD
CY2011Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1531300000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2805200000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2521000000	USD
CY2012Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	262100000	USD
CY2011Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	334000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	586300000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	552000000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-14500000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-150700000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	89400000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	759800000	USD
CY2011Q2	us-gaap	Interest Expense InterestExpense	45100000	USD
	us-gaap	Interest Expense InterestExpense	90900000	USD
	us-gaap	Interest Expense InterestExpense	88300000	USD
CY2012Q2	us-gaap	Interest Expense InterestExpense	43000000	USD
CY2012Q2	us-gaap	Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet	9000000	USD
CY2011Q4	us-gaap	Inventory Net InventoryNet	2299800000	USD
CY2012Q2	us-gaap	Inventory Net InventoryNet	2320800000	USD
CY2012Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	27200000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	53300000	USD
CY2011Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	17800000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	33300000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33659800000	USD
CY2012Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31812600000	USD
CY2012Q2	us-gaap	Liabilities Current LiabilitiesCurrent	6609700000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8930900000	USD
CY2012Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	10895000000	USD
CY2011Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	11193300000	USD
CY2012Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5500200000	USD
CY2011Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5464700000	USD
CY2012Q2	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	1.00
CY2012Q2	us-gaap	Long Term Investments LongTermInvestments	4547600000	USD
CY2011Q4	us-gaap	Long Term Investments LongTermInvestments	4029800000	USD
	us-gaap	Maximum Remaining Maturity Of Foreign Currency Derivatives1 MaximumRemainingMaturityOfForeignCurrencyDerivatives1	P30D
CY2012Q2	us-gaap	Minority Interest MinorityInterest	-2500000	USD
CY2011Q4	us-gaap	Minority Interest MinorityInterest	-6100000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2609700000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1278100000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1939300000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1037600000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2158500000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3216400000	USD
	us-gaap	Net Income Loss NetIncomeLoss	2253200000	USD
CY2011Q2	us-gaap	Net Income Loss NetIncomeLoss	1197300000	USD
	us-gaap	Net Income Loss NetIncomeLoss	1934700000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	923600000	USD
CY2011Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-57600000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-62500000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-68800000	USD
CY2012Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16500000	USD
CY2011Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2493400000	USD
CY2012Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2195000000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-385000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-75600000	USD
CY2011Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	178900000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	660200000	USD
CY2011Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2903500000	USD
CY2012Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2590400000	USD
CY2011Q4	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	121600000	USD
CY2012Q2	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	73300000	USD
CY2011Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1573800000	USD
CY2012Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1472800000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-11200000	USD
CY2011Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-30300000	USD
CY2012Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-700000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-27500000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	19200000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	15200000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	333400000	USD
CY2011Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	166300000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	315600000	USD
CY2012Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	145200000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	111500000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	31400000	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	240400000	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	310200000	USD
	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-608700000	USD
	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-519000000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	1095000000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	1095300000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	199300000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	432800000	USD
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	1636100000	USD
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	3476600000	USD
CY2012Q2	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	2714500000	USD
CY2011Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	3068500000	USD
CY2011Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	813400000	USD
CY2012Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	953300000	USD
	us-gaap	Proceeds From Payments For Long Term Loans For Related Parties ProceedsFromPaymentsForLongTermLoansForRelatedParties	-165000000	USD
	us-gaap	Proceeds From Payments For Long Term Loans For Related Parties ProceedsFromPaymentsForLongTermLoansForRelatedParties	0	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	300000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-128500000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-14700000	USD
CY2011Q2	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	237600000	USD
CY2012Q2	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	1251900000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	498500000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	3635300000	USD
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	2451300000	USD
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	435400000	USD
CY2012Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	14705600000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	14594000000	USD
CY2012Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7619900000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7760300000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1500000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	54600000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2384600000	USD
CY2012Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1320700000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2472200000	USD
CY2011Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1260600000	USD
	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	208600000	USD
CY2011Q2	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	132300000	USD
CY2012Q2	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	0	USD
	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	23800000	USD
CY2012Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	15736200000	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	14897800000	USD
	us-gaap	Revenues Revenues	11202700000	USD
CY2011Q2	us-gaap	Revenues Revenues	6252800000	USD
CY2012Q2	us-gaap	Revenues Revenues	5600700000	USD
	us-gaap	Revenues Revenues	12092000000	USD
CY2011Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	6086500000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	11776400000	USD
CY2012Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	5455500000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	10869300000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3778600000	USD
CY2011Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2043000000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3828700000	USD
CY2012Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1931100000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	65800000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	74200000	USD
CY2012Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	9100000	USD
CY2011Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1522300000	USD
CY2012Q2	us-gaap	Short Term Investments ShortTermInvestments	915700000	USD
CY2011Q4	us-gaap	Short Term Investments ShortTermInvestments	974600000	USD
CY2000	us-gaap	Stock Repurchase Program Authorized Amount StockRepurchaseProgramAuthorizedAmount	3000000000	USD
	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount	419200000	USD
CY2012Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14307900000	USD
CY2011Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13535600000	USD
CY2012Q2	us-gaap	Treasury Stock Value TreasuryStockValue	94300000	USD
CY2011Q4	us-gaap	Treasury Stock Value TreasuryStockValue	95300000	USD
CY2011Q2	lly	Acquired In Process Research And Development AcquiredInProcessResearchAndDevelopment	0	USD
CY2012Q2	lly	Acquired In Process Research And Development AcquiredInProcessResearchAndDevelopment	0	USD
	lly	Acquired In Process Research And Development AcquiredInProcessResearchAndDevelopment	0	USD
	lly	Acquired In Process Research And Development AcquiredInProcessResearchAndDevelopment	388000000	USD
	lly	Acquired In Process Research And Development Net Of Tax AcquiredInProcessResearchAndDevelopmentNetOfTax	0	USD
	lly	Acquired In Process Research And Development Net Of Tax AcquiredInProcessResearchAndDevelopmentNetOfTax	252200000	USD
	lly	Acquisitions Text Block New AcquisitionsTextBlockNew	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Note 3: Acquisitions</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Acquisitions of Businesses</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On February 17, 2012, we acquired all of the outstanding stock of ChemGen Corporation, a privately-held bioscience company specializing in the development and commercialization of innovative feed enzyme products that improve the efficiency of poultry, egg, and meat production, for total purchase consideration of </font><font style="font-family:Arial;font-size:10pt;color:#000000;text-decoration:none;">$206.9 million</font><font style="font-family:Arial;font-size:10pt;"> in cash. </font><font style="font-family:Arial;font-size:10pt;">In connection with this acquisition, we preliminarily recorded </font><font style="font-family:Arial;font-size:10pt;color:#000000;text-decoration:none;">$151.5 million</font><font style="font-family:Arial;font-size:10pt;"> of marketed product assets, with </font><font style="font-family:Arial;font-size:10pt;color:#000000;text-decoration:none;">$55.4 million</font><font style="font-family:Arial;font-size:10pt;"> of other net assets. The final determination may result in asset and liability fair values that differ from the preliminary estimates, but it is not expected that these differences will be material to our consolidated financial statements.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On July 7, 2011, we acquired the animal health business of Janssen Pharmaceutica NV, a Johnson & Johnson company, for total purchase consideration of </font><font style="font-family:Arial;font-size:10pt;color:#000000;text-decoration:none;">$307.8 million</font><font style="font-family:Arial;font-size:10pt;"> in cash. We obtained a portfolio of more than </font><font style="font-family:Arial;font-size:10pt;color:#000000;text-decoration:none;">50</font><font style="font-family:Arial;font-size:10pt;"> animal health products. In connection with this acquisition, we recorded </font><font style="font-family:Arial;font-size:10pt;color:#000000;text-decoration:none;">$234.4 million</font><font style="font-family:Arial;font-size:10pt;"> of marketed product assets and </font><font style="font-family:Arial;font-size:10pt;color:#000000;text-decoration:none;">$29.6 million</font><font style="font-family:Arial;font-size:10pt;"> of acquired in-process research and development (IPR&D) assets, with </font><font style="font-family:Arial;font-size:10pt;color:#000000;text-decoration:none;">$43.8 million</font><font style="font-family:Arial;font-size:10pt;"> of other net assets.</font></div></div>
CY2011Q4	lly	Available For Sale Securities Continuous Unrealized Gain Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedGainPositionFairValue	2498900000	USD
CY2012Q2	lly	Available For Sale Securities Continuous Unrealized Gain Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedGainPositionFairValue	3628100000	USD
	lly	Collaborative Arrangement Income Statement Classification And Amounts CollaborativeArrangementIncomeStatementClassificationAndAmounts	96900000	USD
CY2012Q2	lly	Collaborative Arrangement Income Statement Classification And Amounts CollaborativeArrangementIncomeStatementClassificationAndAmounts	73700000	USD
	lly	Collaborative Arrangement Income Statement Classification And Amounts CollaborativeArrangementIncomeStatementClassificationAndAmounts	145800000	USD
CY2011Q2	lly	Collaborative Arrangement Income Statement Classification And Amounts CollaborativeArrangementIncomeStatementClassificationAndAmounts	51500000	USD
	lly	Cost Of Sales Operating Expenses And Other Net CostOfSalesOperatingExpensesAndOtherNet	9286800000	USD
	lly	Cost Of Sales Operating Expenses And Other Net CostOfSalesOperatingExpensesAndOtherNet	8681700000	USD
CY2012Q2	lly	Cost Of Sales Operating Expenses And Other Net CostOfSalesOperatingExpensesAndOtherNet	4415000000	USD
CY2011Q2	lly	Cost Of Sales Operating Expenses And Other Net CostOfSalesOperatingExpensesAndOtherNet	4721500000	USD
CY2012Q2	lly	Description Of Derivative Activity Volume Percent DescriptionOfDerivativeActivityVolumePercent	0.60
CY2012Q2	lly	Goodwill And Other Intangibles Net GoodwillAndOtherIntangiblesNet	5142800000	USD
CY2011Q4	lly	Goodwill And Other Intangibles Net GoodwillAndOtherIntangiblesNet	5128100000	USD
	lly	Purchased In Process Research And Development PurchasedInProcessResearchAndDevelopment	388000000	USD
	lly	Purchased In Process Research And Development PurchasedInProcessResearchAndDevelopment	0	USD
CY2011Q4	lly	Sales Rebates And Discounts SalesRebatesAndDiscounts	1771300000	USD
CY2012Q2	lly	Sales Rebates And Discounts SalesRebatesAndDiscounts	1628600000	USD
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
	dei	Document Period End Date DocumentPeriodEndDate	2012-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000059478
CY2012Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1160425459	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Lilly Eli & Co
	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes

Files In Submission

Name	View Source	Status
0000059478-12-000006-index-headers.html	Edgar Link	pending
0000059478-12-000006-index.html	Edgar Link	pending
0000059478-12-000006.txt	Edgar Link	pending
0000059478-12-000006-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
lly-20120630.xml	Edgar Link	completed
lly-20120630.xsd	Edgar Link	pending
lly-20120630_cal.xml	Edgar Link	unprocessable
lly-20120630_def.xml	Edgar Link	unprocessable
lly-20120630_lab.xml	Edgar Link	unprocessable
lly-20120630_pre.xml	Edgar Link	unprocessable
lly-6302012x10q.htm	Edgar Link	pending
lly-630x2012x10qxexhibit11.htm	Edgar Link	pending
lly-630x2012x10qxexhibit12.htm	Edgar Link	pending
lly-630x2012x10qxexhibit311.htm	Edgar Link	pending
lly-630x2012x10qxexhibit32.htm	Edgar Link	pending
lly-760x2012x10qxexhibit312.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LLY
ELI LILLY & Co Stock $lly

2012 Q3 Form 10-Q Financial Statement

#000005947812000006 Filed on July 27, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LLY ELI LILLY & Co Stock $lly

2012 Q3 Form 10-Q Financial Statement

#000005947812000006 Filed on July 27, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LLY
ELI LILLY & Co Stock $lly